Medicine
Hydrochlorothiazide 50 mg tablet
Hydrochlorothiazide 50 mg tablet is a generic prescription medicine for oral use, made by 22 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Hydrochlorothiazide
- Brand
- Sold under the generic name
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 500 tablets and 124 more
- Manufacturers
- Avet PharmaceuticalsIndiaUnichem LaboratoriesIndiaAccord HealthcareIndiaAurobindo PharmaIndiaBryant Ranch PrepackSolco HealthcareExelan PharmaceuticalsChartwell RXLeading PharmaOxford Pharmaceuticals22 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C03AA03 Hydrochlorothiazide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 January 1980
- Identifiers
- RxCUI 197770, 310798, 429503DailyMed set ID 8c868894-667e-4a51-906a-838d63e420ba, b5a1b38c-0433-4649-a8b0-f72db0a96c45, e2270db4-2930-4ec5-ac96-2b4542aed367 +36NDC 69315-130, 76282-155, 0172-2089 +36Application ANDA040702, ANDA040907, ANDA083177 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 22 labelers. The register lists 127 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 16729-184-01 | Accord HealthcareIndia | 26 April 2013 |
| 1000 tablet in 1 bottle | 16729-184-17 | Accord HealthcareIndia | 10 April 2013 |
| 100 tablet in 1 bottle | 65862-134-01 | Aurobindo PharmaIndia | 20 July 2007 |
| 1000 tablet in 1 bottle | 65862-134-99 | Aurobindo PharmaIndia | 20 July 2007 |
| 100 tablet in 1 bottle | 23155-009-01 | Avet PharmaceuticalsIndia | 15 January 2015 |
| 500 tablet in 1 bottle | 23155-009-05 | Avet PharmaceuticalsIndia | 15 January 2015 |
| 1000 tablet in 1 bottle | 23155-009-10 | Avet PharmaceuticalsIndia | 15 January 2015 |
| 5000 tablet in 1 bottle | 23155-009-18 | Avet PharmaceuticalsIndia | 1 February 2015 |
| 100 tablet in 1 bottle | 29300-129-01 | Unichem LaboratoriesIndia | 2 July 2009 |
| 500 tablet in 1 bottle | 29300-129-05 | Unichem LaboratoriesIndia | 2 July 2009 |
| 1000 tablet in 1 bottle | 29300-129-10 | Unichem LaboratoriesIndia | 2 July 2009 |
| 5000 tablet in 1 bottle | 29300-129-50 | Unichem LaboratoriesIndia | 2 July 2009 |
| 500 tablet in 1 bottle | 62135-449-05 | Chartwell RX | 19 January 2023 |
| 90 tablet in 1 bottle | 62135-449-90 | Chartwell RX | 19 January 2023 |
| 100 tablet in 1 bottle | 76282-155-01 | Exelan Pharmaceuticals | 30 August 2016 |
| 500 tablet in 1 bottle | 76282-155-05 | Exelan Pharmaceuticals | 30 August 2016 |
| 1000 tablet in 1 bottle | 76282-155-10 | Exelan Pharmaceuticals | 30 August 2016 |
| 90 tablet in 1 bottle | 76282-155-90 | Exelan Pharmaceuticals | 30 August 2016 |
| 100 tablet in 1 bottle, plastic | 69315-130-01 | Leading Pharma | 1 April 2016 |
| 1000 tablet in 1 bottle, plastic | 69315-130-10 | Leading Pharma | 1 April 2016 |
| 100 tablet in 1 bottle | 69584-362-10 | Oxford Pharmaceuticals | 25 September 2020 |
| 1000 tablet in 1 bottle | 69584-362-90 | Oxford Pharmaceuticals | 25 September 2020 |
| 1000 tablet in 1 bottle | 50228-112-10 | ScieGen Pharmaceuticals | 5 February 2014 |
| 30 tablet in 1 bottle | 50228-112-30 | ScieGen Pharmaceuticals | 5 February 2014 |
| 10 tablet in 1 bottle, plastic | 43547-398-01 | Solco Healthcare | 29 March 2002 |
| 30 tablet in 1 bottle, plastic | 43547-398-03 | Solco Healthcare | 29 March 2002 |
| 50 tablet in 1 bottle, plastic | 43547-398-05 | Solco Healthcare | 29 March 2002 |
| 100 tablet in 1 bottle, plastic | 43547-398-10 | Solco Healthcare | 29 March 2002 |
| 1000 tablet in 1 bottle, plastic | 43547-398-11 | Solco Healthcare | 29 March 2002 |
| 500 tablet in 1 bottle, plastic | 43547-398-50 | Solco Healthcare | 29 March 2002 |
| 100 tablet in 1 bottle | 0172-2089-60 | Teva Pharmaceuticals | 8 January 1980 |
| 1000 tablet in 1 bottle | 0172-2089-80 | Teva Pharmaceuticals | 7 January 1980 |
| 100 tablet in 1 bottle | 63629-1220-1 | Bryant Ranch Prepack | 14 January 2021 |
| 30 tablet in 1 bottle, plastic | 63629-8992-1 | Bryant Ranch Prepack | 7 December 2021 |
| 60 tablet in 1 bottle, plastic | 63629-8992-2 | Bryant Ranch Prepack | 7 December 2021 |
| 90 tablet in 1 bottle, plastic | 63629-8992-3 | Bryant Ranch Prepack | 7 December 2021 |
| 45 tablet in 1 bottle | 71335-0145-0 | Bryant Ranch Prepack | 27 December 2021 |
| 30 tablet in 1 bottle | 71335-0145-1 | Bryant Ranch Prepack | 19 February 2018 |
| 60 tablet in 1 bottle | 71335-0145-2 | Bryant Ranch Prepack | 21 May 2019 |
| 90 tablet in 1 bottle | 71335-0145-3 | Bryant Ranch Prepack | 5 April 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 12 February 1959 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Hydrochlorothiazide
Clinical summary
Hydrochlorothiazide is a thiazide diuretic indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. It is available as tablets, capsules and oral solution. MedsAcross supplies Hydrochlorothiazide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about HydrochlorothiazideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Hydrochlorothiazide prescribing information (Actavis Pharma) · U.S. National Library of Medicine, DailyMed
Need Hydrochlorothiazide 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.